This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chow, C. K. Articles by Zujewski, J. Search for Related Content PubMed PubMed Citation Articles by Chow, C. K. Articles by Zujewski, J.

Effect of Tamoxifen on Mammographic Density

Diagnostic Radiology Department, Warren Grant Magnuson Clinical Center [C. K. C., E. C. J., A. P.], Biostatistics and Data Management Section, Division of Clinical Services, National Cancer Institute [D. V.], and Medicine Branch, Division of Clinical Sciences, National Cancer Institute [J. O., J. Z.], NIH, Bethesda Maryland 20892

There are strong data showing that increased breast cancer risk is associated with increased mammographic density. Tamoxifen has been shown to decrease the risk of invasive breast cancer and decrease breast density. We sought to demonstrate and calculate the extent of change in mammographic density in women who have taken tamoxifen for up to 2 years. We evaluated mammograms from 28 high-risk women who were taking tamoxifen. Four different methods of evaluation were used: (a) two qualitative methods (Wolfe criteria and the American College of Radiology Breast Imaging and Reporting Data System criteria); (b) one semiquantitative method (mammograms were assigned one of five semiquantitative scores by visual inspection); and (c) one quantitative method (computer-aided calculation of fibroglandular area from digitized mammograms). The Wolfe criteria showed a 0.03 category decrease per year (P = 0.50). The American College of Radiology Breast Imaging and Reporting Data System criteria showed a 0.1 category decrease per year (P = 0.12). Semiquantitative criteria showed a 0.2 category decrease per year (P = 0.039). Digitized scores showed a 4.3% decrease per year (P = 0.0007). In conclusion, tamoxifen causes a decrease in mammographic density with use, an effect that is better quantitated with semiquantitative criteria or digitized images. Density change might become useful as a surrogate end point for the effect of tamoxifen and other chemopreventive measures, although our data do not predict an individual’s degree of risk reduction.

This article has been cited by other articles:

				P. R. Bakic, A.-K. Carton, D. Kontos, C. Zhang, A. B. Troxel, and A. D. A. Maidment Breast Percent Density: Estimation on Digital Mammograms and Central Tomosynthesis Projections Radiology, July 1, 2009; 252(1): 40 - 49. [Abstract] [Full Text] [PDF]

				A. McTiernan, C.Y. Wang, B. Sorensen, L. Xiao, D. S.M. Buist, E. J. Aiello Bowles, E. White, M. A. Rossing, J. Potter, and N. Urban No Effect of Aspirin on Mammographic Density in a Randomized Controlled Clinical Trial Cancer Epidemiol. Biomarkers Prev., May 1, 2009; 18(5): 1524 - 1530. [Abstract] [Full Text] [PDF]

				J. J. Heine, M. J. Carston, C. G. Scott, K. R. Brandt, F.-F. Wu, V. S. Pankratz, T. A. Sellers, and C. M. Vachon An Automated Approach for Estimation of Breast Density Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3090 - 3097. [Abstract] [Full Text] [PDF]

				Y. Shen, J. P. Costantino, and J. Qin Tamoxifen Chemoprevention Treatment and Time to First Diagnosis of Estrogen Receptor-Negative Breast Cancer J Natl Cancer Inst, October 15, 2008; 100(20): 1448 - 1453. [Abstract] [Full Text] [PDF]

				J. Eng-Wong, J. Orzano-Birgani, C. K. Chow, D. Venzon, J. Yao, C. E. Galbo, J. A. Zujewski, and S. Prindiville Effect of Raloxifene on Mammographic Density and Breast Magnetic Resonance Imaging in Premenopausal Women at Increased Risk for Breast Cancer Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1696 - 1701. [Abstract] [Full Text] [PDF]

				E. S. Hwang, D. L. Miglioretti, R. Ballard-Barbash, D. L. Weaver, K. Kerlikowske, and for the National Cancer Institute Breast Cancer Su Association between Breast Density and Subsequent Breast Cancer Following Treatment for Ductal Carcinoma In situ Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2587 - 2593. [Abstract] [Full Text] [PDF]

				R. M. Tamimi, C. Byrne, G. A. Colditz, and S. E. Hankinson Endogenous Hormone Levels, Mammographic Density, and Subsequent Risk of Breast Cancer in Postmenopausal Women J Natl Cancer Inst, August 1, 2007; 99(15): 1178 - 1187. [Abstract] [Full Text] [PDF]

				K. Kerlikowske, L. Ichikawa, D. L. Miglioretti, D. S. M. Buist, P. M. Vacek, R. Smith-Bindman, B. Yankaskas, P. A. Carney, and R. Ballard-Barbash Longitudinal Measurement of Clinical Mammographic Breast Density to Improve Estimation of Breast Cancer Risk J Natl Cancer Inst, March 7, 2007; 99(5): 386 - 395. [Abstract] [Full Text] [PDF]

				M. R. Palomares, J. R.B. Machia, C. D. Lehman, J. R. Daling, and A. McTiernan Mammographic density correlation with gail model breast cancer risk estimates and component risk factors. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1324 - 1330. [Abstract] [Full Text] [PDF]

				R. M. Tamimi, S. E. Hankinson, G. A. Colditz, and C. Byrne Endogenous Sex Hormone Levels and Mammographic Density among Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2641 - 2647. [Abstract] [Full Text] [PDF]

				L. A. Habel, J. J. Dignam, S. R. Land, M. Salane, A. M. Capra, and T. B. Julian Mammographic Density and Breast Cancer After Ductal Carcinoma In Situ J Natl Cancer Inst, October 6, 2004; 96(19): 1467 - 1472. [Abstract] [Full Text] [PDF]

				C. L. Frankenfeld, A. McTiernan, E. J. Aiello, W. K. Thomas, K. LaCroix, J. Schramm, S. M. Schwartz, V. L. Holt, and J. W. Lampe Mammographic Density in Relation to Daidzein-Metabolizing Phenotypes in Overweight, Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., July 1, 2004; 13(7): 1156 - 1162. [Abstract] [Full Text] [PDF]

				E. Ziv, J. Shepherd, R. Smith-Bindman, and K. Kerlikowske Mammographic Breast Density and Family History of Breast Cancer J Natl Cancer Inst, April 2, 2003; 95(7): 556 - 558. [Abstract] [Full Text] [PDF]

				R. T. Chlebowski and A. McTiernan Biological Significance of Interventions That Change Breast Density J Natl Cancer Inst, January 1, 2003; 95(1): 4 - 5. [Full Text] [PDF]

				G. A. Greendale, B. A. Reboussin, S. Slone, C. Wasilauskas, M. C. Pike, and G. Ursin Postmenopausal Hormone Therapy and Change in Mammographic Density J Natl Cancer Inst, January 1, 2003; 95(1): 30 - 37. [Abstract] [Full Text] [PDF]

				C. M. Vachon, T. A. Sellers, R. A. Vierkant, F.-F. Wu, and K. R. Brandt Case-Control Study of Increased Mammographic Breast Density Response to Hormone Replacement Therapy Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1382 - 1388. [Abstract] [Full Text] [PDF]

				S. Prevrhal, J. A Shepherd, R. Smith-Bindman, S. R. Cummings, and K. Kerlikowske Accuracy of Mammographic Breast Density Analysis: Results of Formal Operator Training Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1389 - 1393. [Abstract] [Full Text] [PDF]

				J. A. Shepherd, K. M. Kerlikowske, R. Smith-Bindman, H. K. Genant, and S. R. Cummings Measurement of Breast Density with Dual X-ray Absorptiometry: Feasibility Radiology, May 1, 2002; 223(2): 554 - 557. [Abstract] [Full Text] [PDF]

				M. Messina, C. Gardner, and S. Barnes Gaining Insight into the Health Effects of Soy but a Long Way Still to Go: Commentary on the Fourth International Symposium on the Role of Soy in Preventing and Treating Chronic Disease J. Nutr., March 1, 2002; 132(3): 547S - 551. [Abstract] [Full Text] [PDF]

				K. W. Singletary and S. M. Gapstur Alcohol and Breast Cancer: Review of Epidemiologic and Experimental Evidence and Potential Mechanisms JAMA, November 7, 2001; 286(17): 2143 - 2151. [Abstract] [Full Text] [PDF]